Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kate A Markey

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Blood Advances|June 9, 2026
Plant-based whole-food diets are feasible during auto-HCT and are associated with dose-dependent microbiome modulationKatherine Ueland, Taara Elahi, Mary Rasmussen, et al.
Blood|January 21, 2022
Early intestinal microbial features are associated with CD4 T-cell recovery after allogeneic hematopoietic transplantOriana Miltiadous, Nicholas R Waters, Hana Andrlová, et al.
Blood|October 15, 2021
Alloreactive T cells deficient of the short-chain fatty acid receptor GPR109A induce less graft-versus-host diseaseMelissa D Docampo, Marina B da Silva, Amina Lazrak, et al.
Immunity|July 22, 2023
Intestinal microbiota controls graft-versus-host disease independent of donor-host genetic disparityMotoko Koyama, Daniel S Hippe, Sujatha Srinivasan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 2, 2022
Conditioning Regimens are Associated with Distinct Patterns of Microbiota Injury in Allogeneic Hematopoietic Cell TransplantationRoni Shouval, Nicholas R Waters, Antonio L C Gomes, et al.
Nature Microbiology|March 1, 2024
Altered microbial bile acid metabolism exacerbates T cell-driven inflammation during graft-versus-host diseaseSarah Lindner, Oriana Miltiadous, Ruben J F Ramos, et al.
Cancer Immunology Research|December 18, 2023
Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota TransplantationArielle Elkrief, Nicholas R Waters, Natalie Smith, et al.
Cell|June 9, 2023
High-resolution analyses of associations between medications, microbiome, and mortality in cancer patientsChi L Nguyen, Kate A Markey, Oriana Miltiadous, et al.
Blood|January 29, 2021
Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational studyNiloufer Khan, Sarah Lindner, Antonio L C Gomes, et al.
Science Translational Medicine|May 25, 2022
MAIT and Vδ2 unconventional T cells are supported by a diverse intestinal microbiome and correlate with favorable patient outcome after allogeneic HCTHana Andrlová, Oriana Miltiadous, Anastasia I Kousa, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Blood Advances|June 9, 2026
Plant-based whole-food diets are feasible during auto-HCT and are associated with dose-dependent microbiome modulationKatherine Ueland, Taara Elahi, Mary Rasmussen, et al.
Blood|January 21, 2022
Early intestinal microbial features are associated with CD4 T-cell recovery after allogeneic hematopoietic transplantOriana Miltiadous, Nicholas R Waters, Hana Andrlová, et al.
Blood|October 15, 2021
Alloreactive T cells deficient of the short-chain fatty acid receptor GPR109A induce less graft-versus-host diseaseMelissa D Docampo, Marina B da Silva, Amina Lazrak, et al.
Immunity|July 22, 2023
Intestinal microbiota controls graft-versus-host disease independent of donor-host genetic disparityMotoko Koyama, Daniel S Hippe, Sujatha Srinivasan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 2, 2022
Conditioning Regimens are Associated with Distinct Patterns of Microbiota Injury in Allogeneic Hematopoietic Cell TransplantationRoni Shouval, Nicholas R Waters, Antonio L C Gomes, et al.
Nature Microbiology|March 1, 2024
Altered microbial bile acid metabolism exacerbates T cell-driven inflammation during graft-versus-host diseaseSarah Lindner, Oriana Miltiadous, Ruben J F Ramos, et al.
Cancer Immunology Research|December 18, 2023
Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota TransplantationArielle Elkrief, Nicholas R Waters, Natalie Smith, et al.
Cell|June 9, 2023
High-resolution analyses of associations between medications, microbiome, and mortality in cancer patientsChi L Nguyen, Kate A Markey, Oriana Miltiadous, et al.
Blood|January 29, 2021
Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational studyNiloufer Khan, Sarah Lindner, Antonio L C Gomes, et al.
Science Translational Medicine|May 25, 2022
MAIT and Vδ2 unconventional T cells are supported by a diverse intestinal microbiome and correlate with favorable patient outcome after allogeneic HCTHana Andrlová, Oriana Miltiadous, Anastasia I Kousa, et al.
Pageof 8